Kentaro Ono

Dr. Kentaro Ono


Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Pharmacological Research
Verified
Journal Article
Closed access
SHSuzuro Hitomi
Suzuro Hitomi
KOKentaro Ono
Kentaro Ono
KTKiyoshi Terawaki
Kiyoshi Terawaki
CMChinami Matsumoto
Chinami Matsumoto
KMKeita Mizuno
Keita Mizuno
KIKiyotoshi Inenaga
Kiyotoshi Inenaga

5 June 2014 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
YYYi Ye
Yi Ye
KOKentaro Ono
Kentaro Ono
DBDaniel G Bernabé
Daniel G Bernabé
CVChi T Viet
Chi T Viet
VPVictoria Pickering
Victoria Pickering
BSBrian Schmidt
Brian Schmidt
Cancer pain creates a poor quality of life and decreases survival. The basic neurobiology of cancer pain is poorly understood. Adenosine triphosphate (ATP) and the ATP ionotropic receptor subunits, P2X2 and P2X3, mediate cancer pain in animal models; however, it is unknown whether this mechanism operates in human, and if so, what the relative contribution of P2X2- and P2X3-containing trimeric channels to cancer pain is. Here, we studied head and neck squamous cell carcinoma (HNSCC), which causes the highest level of function-induced pain relative to other types of cancer.

1 June 2016 in Archives of Oral Biology
Verified
Journal Article
Closed access
HSHitomi suzuro
Hitomi suzuro
KOKentaro Ono
Kentaro Ono
KYKiichiro Yamaguchi
Kiichiro Yamaguchi
KTKiyoshi Terawaki
Kiyoshi Terawaki
RIRyota Imai
Ryota Imai
KIKiyotoshi Inenaga
Kiyotoshi Inenaga

1 January 2015 in Journal of Neuroscience Methods
Verified
Journal Article
Closed access
SHSuzuro Hitomi
Suzuro Hitomi
KOKentaro Ono
Kentaro Ono
KMKanako Miyano
Kanako Miyano
YOYojiro Ota
Yojiro Ota
YUYasuhito Uezono
Yasuhito Uezono
KIKiyotoshi Inenaga
Kiyotoshi Inenaga

1 February 2020 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
AMAoi Morii
Aoi Morii
YMYuichi Miyamura
Yuichi Miyamura
MSMisa I. Sago
Misa I. Sago
MMMasahiro Mizuhara
Masahiro Mizuhara
TSTakemi Shikayama
Takemi Shikayama
KOKentaro Ono
Kentaro Ono

1 January 2017 in Molecular Pain
Verified
Journal Article
Open access
MIMisa Ito
Misa Ito
KOKentaro Ono
Kentaro Ono
SHSuzuro Hitomi
Suzuro Hitomi
TNTomotaka Nodai
Tomotaka Nodai
TSTeppei Sago
Teppei Sago
KIKiyotoshi Inenaga
Kiyotoshi Inenaga
During dental treatments, intraoral appliances frequently induce traumatic ulcers in the oral mucosa. Such mucosal injury-induced mucositis leads to severe pain, resulting in poor quality of life and decreased cooperation in the therapy. To elucidate mucosal pain mechanisms, we developed a new rat model of intraoral wire-induced mucositis and investigated pain mechanisms using our proprietary assay system for conscious rats. A thick metal wire was installed in the rats between the inferior incisors for one day. In the mucosa of the mandibular labial fornix region, which was touched with a free end of the wire, traumatic ulcer and submucosal abscess were induced on day 1. The ulcer was quickly cured until next day and abscess formation was gradually disappeared until five days. Spontaneous nociceptive behavior was induced on day 1 only, and mechanical allodynia persisted over day 3. Antibiotic pretreatment did not affect pain induction. Spontaneous nociceptive behavior was sensitive to indomethacin (cyclooxygenase inhibitor), ONO-8711 (prostanoid receptor EP1 antagonist), SB-366791, and HC-030031 (TRPV1 and TRPA1 antagonists, respectively). Prostaglandin E2 and 15-deoxyΔ12,14-prostaglandin J2 were upregulated only on day 1. In contrast, mechanical allodynia was sensitive to FSLLRY-NH2 (protease-activated receptor PAR2 antagonist) and RN-1734 (TRPV4 antagonist). Neutrophil elastase, which is known as a biased agonist for PAR2, was upregulated on days 1 to 2. These results suggest that prostanoids and PAR2 activation elicit TRPV1- and TRPA1-mediated spontaneous pain and TRPV4-mediated mechanical allodynia, respectively, independently of bacterial infection, following oral mucosal trauma. The pathophysiological pain mechanism suggests effective analgesic approaches for dental patients suffering from mucosal trauma-induced pain.